Pontifax Management 4 G.P. (2015) Ltd.'s Form 4 filing
LB Pharmaceuticals Inc (LBRX) · filed Sep 16, 2025
- Accession no.
- 0001726334-25-000003
- Filed
- Sep 16, 2025
- Trade date
- Sep 12, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market purchases total $15.0M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Pontifax Management 4 G.P. (2015) Ltd.CIK 0001726334 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Common Stock | CConversionAcquired | +411,681 | – | – | 411,681 | Indirect | Duplicate filing |
| Sep 12, 2025 | Common Stock | PPurchaseAcquired | +1,000,000 | $15.00 | +$15,000,000 | 1,411,681 | Indirect | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Common Stock | CConversionDisposed | −411,681 | – | – | 0 | Indirect | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.